CNS & Neurological Disorders - Drug Targets
Title:Meet Our Editorial Board Member
Volume: 15 Issue: 4
Author(s): Antonio E. Nardi
Affiliation:
Export Options
About this article
Cite this article as:
Nardi E. Antonio, Meet Our Editorial Board Member, CNS & Neurological Disorders - Drug Targets 2016; 15 (4) . https://dx.doi.org/10.2174/187152731504160328163417
DOI https://dx.doi.org/10.2174/187152731504160328163417 |
Print ISSN 1871-5273 |
Publisher Name Bentham Science Publisher |
Online ISSN 1996-3181 |
17
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Dual Acting Isatin-heterocyclic Hybrids: Recent Highlights as Promising Pharmacological Agents
Letters in Drug Design & Discovery Vitamin D Analogs: Mechanism of Action and Therapeutic Applications
Current Medicinal Chemistry Are Some Drinkers Resistant to Hangover? A Literature Review
Current Drug Abuse Reviews Competitive Intelligence Tools for University-Based Technology Transfer Offices
Technology Transfer and Entrepreneurship (Discontinued) Biotechnological Potential of Sponge-Associated Bacteria
Current Pharmaceutical Biotechnology Hydrogen Sulfide: A New Tool to Design and Develop Drugs
Clinical Anti-Inflammatory & Anti-Allergy Drugs (Discontinued) Predictors of Ominous Outcome in Infants who Undergo Cardiac Surgery and Cardiopulmonary By-Pass: S100B Protein
CNS & Neurological Disorders - Drug Targets Application of Pharmacogenomic Approaches in the Study of Drug Response in Complex Diseases
Current Pharmacogenomics Cognitive Behavioral Therapy in Prodromal Psychosis
Current Pharmaceutical Design Blockade of the Cannabinoid CB1 Receptor and Alcohol Dependence: Preclinical Evidence and Preliminary Clinical Data
CNS & Neurological Disorders - Drug Targets Serotonin and Cognitive Flexibility: Neuroimaging Studies into the Effect of Acute Tryptophan Depletion in Healthy Volunteers
Current Medicinal Chemistry Efficacy of Gene Therapy to Restore Cognition in Alzheimer’s Disease: A Systematic Review
Current Gene Therapy Analgesia in PACU: Indications, Monitoring, Complications
Current Drug Targets Nanostructured Lipid Carriers (NLCs): Nose-to-Brain Delivery and Theranostic Application
Current Drug Metabolism <i>Arthrophytum scoparium</i> Extract Improves Memory Impairment and Affects Acetylcholinesterase Activity In Mice Brain
Current Pharmaceutical Biotechnology Chemotherapy Delivery Strategies to the Central Nervous System: neither Optional nor Superfluous
Current Cancer Drug Targets Catatonia: A Narrative Review
Central Nervous System Agents in Medicinal Chemistry Identification of Key mRNAs, miRNAs, and mRNA-miRNA Network Involved in Papillary Thyroid Carcinoma
Current Bioinformatics Understanding Genetic Factors in Idiopathic Scoliosis, a Complex Disease of Childhood
Current Genomics Topical Diclofenac-Loaded Liposomes Ameliorate Laser-Induced Choroidal Neovascularization in Mice and Non-Human Primates
Current Neurovascular Research